TCT-261 Intra-aortic balloon pump therapy does not reduce mortality in acute myocardial infarction, with or without cardiogenic shock: application of a baseline inequality index to account for differential outcomes in randomized and observational studies
Ahmad Y, Sen S, Shun-Shin M, Cole G, Finegold J, Al-Lamee R, Nijjer S, Petraco R, Cook C, Malik I, Baker C, Davies J, Mayet J, Francis D. TCT-261 Intra-aortic balloon pump therapy does not reduce mortality in acute myocardial infarction, with or without cardiogenic shock: application of a baseline inequality index to account for differential outcomes in randomized and observational studies. Journal Of The American College Of Cardiology 2015, 66: b103. DOI: 10.1016/j.jacc.2015.08.944.Peer-Reviewed Original ResearchIntra-aortic Balloon Pump Therapy for Acute Myocardial Infarction: A Meta-analysis
Ahmad Y, Sen S, Shun-Shin MJ, Ouyang J, Finegold JA, Al-Lamee RK, Davies JER, Cole GD, Francis DP. Intra-aortic Balloon Pump Therapy for Acute Myocardial Infarction: A Meta-analysis. JAMA Internal Medicine 2015, 175: 931-939. PMID: 25822657, DOI: 10.1001/jamainternmed.2015.0569.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionIntra-aortic balloon pump therapyUse of IABPMyocardial infarctionObservational studyCardiogenic shockPump therapyIntra-aortic balloon pumpNon-IABP groupThirty-day mortalityAcute coronary syndromeEligible observational studiesRisk of biasIABP efficacyIABP useEligible RCTsCochrane riskCoronary syndromeIABP therapyBalloon pumpBias toolCochrane LibraryClinical trialsRisk factorsSTUDY SELECTION